Effect of ksheerabala taila (101) as nasal instillation & chandraprabha vati as an adjuvent in the management of primary open angle glaucoma.

EFFECT OF KSHEERABALA TAILA (101) PRATIMARSHA NASYA & CHANDRAPRABHA VATI AS AN ADJUVANT WITH STANDARD CONTROL IN THE MANAGEMENT OF KAPHAJA ADHIMANTHA-PRIMARY OPEN ANGLE GLAUCOMA â?? AN OPEN LABELLED DOUBLE ARM RANDOMIZED STANDARD CONTROL CLINICAL TRIAL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/06/054360

Enrollment

Registered

2023-06-23

Start date

Unknown

Completion date

Unknown

Last updated

2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H401- Open-angle glaucoma

Interventions

Intervention1: chandraprabha vati and ksheerabala (101) pratimarsha nasya: chandraprabha will be given 2 bd ksheerabala(101) 2 drops a day twice for 8 weeks Control Intervention1: ksheerabala(101) and

Eligibility

Inclusion criteria

Inclusion criteria: 1.IOP up to 30 mm Hg 2.normo tensive glaucoma of Intra ocular Pressure less than 21 mm Hg 3.Best corrected visual acuity more than 6/60 and clear media

Exclusion criteria

Exclusion criteria: all type of posterior angle closure glaucoma & cataract end stage glaucoma or Optic atrophy best corrected visual acuity less than 6/60 secondary & developmental glaucoma including exfoliative glaucoma pigmentary glaucoma trauma induced glaucoma inflammatory glaucoma

Design outcomes

Primary

Measure	Time frame
evaluate the adjuvant effect of Ksheerabala taila Pratimarsha nasya and Chandraprabha Vati in the symptoms of Kaphaja adhimantha (POAG).Timepoint: 8 week	—

Secondary

Measure	Time frame
evaluate the adjuvant effect of Ksheerabala taila Pratimarsha nasya & Chandraprabha Vati in the management of Kaphaja adhimantha(POAG) of visual symptomsTimepoint: 8 weeks	—

Countries

India

Contacts

Public ContactDr Bijayashree Dash

All India Institute of Ayurveda, new delhi

dbijayashree@gmail.com7001408482

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026